Overview
Usually not — and the reason is straightforward once you know what progesterone is doing in a hormone therapy regimen.
Progesterone is prescribed alongside systemic estrogen to protect the lining of the uterus. Estrogen stimulates the endometrium, and unopposed stimulation over time increases the risk of endometrial hyperplasia and endometrial cancer. Progesterone opposes that.
No uterus means no endometrium to protect, which means the reason for the progestogen no longer applies. Standard practice after a total hysterectomy is estrogen alone.
| Situation | Progestogen usually needed? |
|---|---|
| Total hysterectomy (uterus and cervix removed) | No — no endometrium remains |
| Subtotal / supracervical (cervix retained) | Usually not, but see below — residual endometrial tissue is possible |
| History of endometriosis | Sometimes — deposits outside the uterus can respond to estrogen |
| History of endometrial cancer | Specialist decision. Not a general rule |
| Uterus present | Yes — always, with systemic estrogen |
Why this matters beyond convenience: adding an unnecessary progestogen is not neutral. It carries its own effects — mood changes, bloating, breast tenderness — and the increase in breast cancer signal seen in the large trials came from the combined arm rather than the estrogen-only arm. Taking a progestogen you do not need adds those considerations for no protective benefit.
Why the estrogen-only distinction matters
This is one of the more consequential findings in the whole field and it is widely under-reported.
The Women's Health Initiative had two arms. The combined estrogen-plus-progestin arm reported an increased breast cancer signal — the finding that reshaped prescribing for a generation. The estrogen-alone arm, in women who had had a hysterectomy, did not show the same increase.
Which means that for a woman without a uterus, the risk picture around hormone therapy looks different from the one most people carry in their heads — and that impression was formed largely from the combined arm. What the trial actually tested.
That is not a reason to take estrogen casually. It is a reason to know that the risk conversation for a woman post-hysterectomy is genuinely a different conversation.
The exceptions, and how real each one is
Subtotal or supracervical hysterectomy. If the cervix was retained, a small amount of endometrial tissue can occasionally remain in the lower segment. Most women in this situation still do not need a progestogen — but it is worth knowing which operation you had, and many women do not. Your operation note or your surgeon can confirm it, and it is worth establishing before starting rather than assuming.
Endometriosis. Endometrial-type tissue outside the uterus can persist after hysterectomy and can respond to estrogen. Where endometriosis was extensive, some clinicians add a progestogen or use a different approach. This is genuinely individual and depends on how much disease was present and what was removed.
History of endometrial cancer. Hormone therapy after endometrial cancer is a specialist decision involving the oncology team, and general rules do not apply.
Endometrial ablation is a different procedure from hysterectomy — the uterus remains. A progestogen is still required with systemic estrogen after ablation, because endometrial tissue remains even though bleeding may have stopped. This is a genuine and dangerous point of confusion.
What "hysterectomy" actually covers
Worth clarifying, because the terms are used loosely and the distinctions change the answer.
Total hysterectomy — uterus and cervix removed. The ovaries may or may not have been removed; that is a separate question.
Subtotal or supracervical hysterectomy — uterus removed, cervix left in place.
Radical hysterectomy — more extensive, generally for cancer.
With or without oophorectomy — whether the ovaries were also removed. This does not affect the progestogen question, but it matters enormously for everything else: a woman whose ovaries were removed before natural menopause experiences abrupt, complete estrogen loss, and treatment is generally recommended at least until the usual age of menopause for bone and cardiovascular reasons. Why early menopause is a different conversation.
If you are unsure which operation you had, it is worth finding out. It changes what you need.
What else changes without a uterus
Route options widen. Without a progestogen to accommodate, there are more straightforward estrogen-only options.
No bleeding to interpret. Which removes a monitoring signal — one reason a woman with a uterus has a bleeding pattern to watch. What that involves.
The risk conversation shifts, as above.
But everything else still applies. Cardiovascular and clot risk assessment, blood pressure, route choice, and a periodic review of whether treatment is still doing what it was started for. Not needing a progestogen does not simplify the rest of it.
Frequently asked questions
Do I need progesterone after a hysterectomy? Usually not. Progesterone is prescribed to protect the uterine lining, and without a uterus there is no lining to protect. Standard practice is estrogen alone.
What if I had a partial hysterectomy? If the cervix was retained, a small amount of endometrial tissue can occasionally remain. Most women still do not need a progestogen, but it is worth confirming which operation you had.
What if I had endometriosis? Endometrial-type tissue outside the uterus can persist and respond to estrogen. Some clinicians add a progestogen where disease was extensive. It is an individual decision.
What about after an endometrial ablation? Different procedure — the uterus remains, so a progestogen is still required with systemic estrogen. This is a common and important point of confusion.
Is estrogen-only safer? The large trial's increased breast cancer signal came from the combined arm; the estrogen-only arm did not show the same increase. It is a different risk picture, which is worth discussing rather than assuming either way.
Where this fits in your plan
The practical step is knowing exactly which operation you had, because that determines whether the general answer applies to you.
From there the conversation is about route, cardiovascular and clot risk, and what you are treating — the same assessment as anyone else, minus one component. What hormone therapy with us involves.
We measure first. Then we act.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
